Nitropress

Pharma

FDA generics push hits Valeant price-hike poster child Isuprel

Scott Gottlieb said his FDA would speed generics to market, and that effort boasts an early branded victim: Valeant’s controversial heart med Isuprel.

Eric Sagonowsky Aug 7, 2017 9:17am

Pharma treads lightly in early-year price hikes

Feb 27, 2017 12:14pm